Prostate Cancer Cells Show Tendency to Spread With Specific Gene Function Loss

A new research has shown that prostate cancer cells are more likely to spread to other parts of the body if a specific gene quits functioning normally.

Washington, Feb 3 (ANI): A new research has shown that prostate cancer cells are more likely to spread to other parts of the body if a specific gene quits functioning normally.

Certain prostate cancer cells can be held in check by the DAB2IP gene. The gene's product, the DABIP protein, acts as scaffolding that prevents many other proteins involved in the progression of prostate cancer cells from over-activation.

Prostate Cancer Diagnosis Leads to Immediate Risk of Suicide and Cardiovascular Death
Study says being diagnosed with prostate cancer may increase a man's risk of suicide or cardiovascular death, especially right after diagnosis

However, when those cells lose the DAB2IP protein, they break free and are able to metastasize, or spread, drastically increasing the risk of cancer progression in other organs as the cells travel through the bloodstream or lymph system.

The study in mice found that eliminating the DAB2IP scaffolding in human carcinoma cells caused them to change from epithelial cells to mesenchymal cells - a hallmark of metastatic cancer.

"Cells undergoing an epithelial to mesenchymal transition (EMT) experience biological changes that enable them to move freely and spontaneously throughout the body," said Dr. Jer-Tsong Hsieh, from UT Southwestern Medical Center and the study's senior author.

Prostate Cancer is Treated Differently at Private Hospitals, Study Says
Prostate cancer treatments vary significantly between county hospitals and private providers, researchers at Moores Cancer Center at the University of California, San Diego and colleagues have found

"By restoring DAB2IP function in cancer cells in mice, we reversed their ability to change and metastasise," Hsieh added.

Hsieh said that identifying the DAB2IP protein in human cells might serve as a biomarker, helping physicians identify patients who could have more aggressive, metastatic forms of prostate cancer.

False Positive Results of Prostate Cancer Test Cause Concern
Concerns have been raised by researchers over false positive results of prostate cancer screening.

EMT is known to play an important role in embryo implantation, embryogenesis and organ development, and tissue regeneration, as well as in cancer progression and metastasis. For cancer progression, EMT is believed to facilitate the migratory and invasive ability of cancer cells.

"Carcinoma cells undergo several changes that enable them to spread. The majority of human visceral tumours derived from carcinomas are primarily made up of epithelial cells. When they acquire mesenchymal phenotypes, they lose cell-to-cell adhesion and become more mobile throughout the body," Hsieh said.

New Prostate Cancer Research Projects to be Funded by PCF
The Prostate Cancer Foundation (PCF) has announced that it will fund 30 new projects in all to promote innovative cancer research.

In the current study, Dr. Hsieh and his team first shut down the DAB2IP gene expression in prostate epithelial cells in mice and found that the prostate cancers did indeed metastasize to lymph nodes and other organs in mice.

When the researchers restored the DAB2IP genetic function to metastatic prostate cancer cells, the EMT process reversed, thereby inhibiting the cancer cells' ability to spread.

The study has been published in the Jan. 11 issue of the Proceedings of the National Academy of Sciences.

Source-ANI
SAV